Searched for
BHARAT BIOTECH
Balrampur Chini gets government grant for biopolymer R&D facilityBalrampur Chini Mills Ltd (BCML) has received ₹75 crore in grant assistance from the government to set up a pilot-scale research and develo...- Bharat Biotech is 'back in action' after Covid reset: Krishna Ella on TB vaccine, Nipah-Ebola shots, gene therapy, IPO plans & what’s nextBharat Biotech is “back in action” after a two-year post-Covid reset, founder Krishna Ella says, with the company expanding beyond vaccines...
- RBI weighs Anup Bagchi for HDFC top job; seeks feedback from Irda, ICICI Bank on his candidature due to 3-year gap from mainstream bankingThe Reserve Bank of India is actively seeking opinions on the possible appointment of Anup Bagchi as CEO of HDFC Bank. Currently with ICICI...
- TTD to offer Rs 2 lakh insurance to devotees; Andhra Pradesh CM Naidu announces major temple development plansTirumala Tirupati Devasthanams will offer insurance coverage to every devotee through LIC. The temple trust also plans to construct new Sri...
- Independence Day 2026: India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...
- Vaccine maker Bharat Biotech said to mull $500 million IPOIndian vaccine developer Bharat Biotech International Ltd. is considering an initial public offering that may raise more than $500 million,...
- Bharat Biotech, GSK join hands to develop vaccine for severe diarrhoeaBharat Biotech and GSK plc have partnered to develop a vaccine for Shigellosis, a severe bacterial diarrhea. The altSonflex1-2-3 vaccine ca...
- Bharat Biotech launches oral cholera vaccine Hillchol after positive phase 3 trialBharat Biotech unveiled Hillchol, a new single-strain oral cholera vaccine, developed with Hilleman Laboratories. Addressing the high globa...
- Bharat Biotech credited ICMR, NIV as Covaxin co-inventors after missing them initially: GovernmentResponding to Trinamool Congress member Sougata Roy, who had asked whether the government took any punitive action against the company for ...
- Bharat Biotech, Bilthoven Biologicals collaborate for oral polio vaccines production, supplyBharat Biotech on Tuesday said it has collaborated with the Netherlands-based Bilthoven Biologicals B.V, a wholly-owned arm of Serum Instit...
- Japan recognises Covaxin to facilitate travel from April 10: Bharat BiotechJapan has included Bharat Biotech's Covaxin in the list of recognised vaccines, a move aimed at facilitating travel between the two countri...
- Awaiting regulatory approvals to launch Covaxin for children: Bharat Biotech"This represents one of the first approvals worldwide for COVID-19 vaccines for the 2-18 age group. Bharat Biotech sincerely thanks the DCG...
- Decision on Bharat Biotech's Covaxin EUL in October, says WHOThe latest 'Status of COVID-19 vaccines within WHO EUL/PQ evaluation process' guidance document dated September 29 on the WHO website said ...
- Bharat Biotech, IVI launch Chikungunya Vaccine Phase 2/3 trial in Costa RicaCEPI first partnered with IVI and Bharat Biotech in June 2020, providing up to USD 14.1 million for vaccine manufacturing and clinical deve...
- Covaxin receives GMP certificate from Hungary: Bharat BiotechBharat Biotech intends to submit documentation for emergency use authorisation to several additional countries worldwide, the company said.
- COVAXIN: News reports on submitting Phase-3 data to WHO is incorrect, says Bharat BiotechBharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use...
- How Krishna Ella built Bharat Biotech and why the company is at a tipping pointBharat Biotech’s Covaxin is India’s first indigenous coronavirus vaccine. The DCGI’s approval of Covaxin, despite it not having phase-3 cli...
- Bharat Biotech's top brass calls on vice presidentThe indigenous, inactivated vaccine is being developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) bio-containment faci...
- Bharat Biotech completes recruitment of 13,000 volunteers for Phase III trials of CovaxinBharat Biotech has signed up 13,000 volunteers for the Phase 3 trial, backed by India's government medical research body, and is progressin...
- Bharat Biotech begins Phase-III trials for COVID-19 vaccine, Covaxin, with 26,000 volunteers"This is India's first phase-III efficacy study for a Covid-19 vaccine, and the largest phase-III efficacy trial ever conducted in India," ...
Load More
